Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
2010
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
2009 Standout
Spinal cord gray matter atrophy correlates with multiple sclerosis disability
2014
Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes
2014
NF-κB signaling in inflammation
2017 Standout
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate
2014
Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
2018
The cerebellum and cognition
2018 Standout
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
On the Clinical Pharmacology of Reactive Oxygen Species
2020
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
2015
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
2011 Standout
Amyotrophic lateral sclerosis
2011 Standout
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity
2011
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Cytokine Secretion Pattern in Treatment of Lymphocytes of Multiple Sclerosis Patients with Fumaric Acid Esters
2011
Multiple sclerosis
2008 Standout
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
2008
Biomarkers in amyotrophic lateral sclerosis
2008
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
2012
The cytoprotective role of the Keap1–Nrf2 pathway
2011
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Immunopathology of multiple sclerosis
2015 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
2014 Standout
Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
2008
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
2013
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis
2016
Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value
2015
An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
2017
Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative Disorders
2010
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
2006
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Multiple Sclerosis
2018 Standout
Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
2017
Dimethyl fumarate for multiple sclerosis
2015
Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis
2015
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
2019
Dimethyl Fumarate
2013
Cervical cord lesion load is associated with disability independently from atrophy in MS
2014
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
2015
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
2018
Progressive cognitive dysfunction in spinocerebellar ataxia type 3
2013
Business Artificial Intelligence
2021 Standout
Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
2016
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Barbara Bellenberg being referenced
1H-Magnetic Resonance Spectroscopy in diffuse and focal cervical cord lesions in Multiple Sclerosis
2013
Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: A voxel-based morphometry study
2006
Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study
2017
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability
2015
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open‐label, baseline‐controlled pilot study
2006
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis
2014
Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model.
2007
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients
2013